stationary phase raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-08-21 and is reviewed periodically as new material appears.
Key performance measures include retention time, peak area, peak height, resolution, tailing factor, and plate count. Retention time helps identify a peak under fixed conditions, but confirmation often requires a second method or detector. Peak area and height relate to concentration through calibration curves, which may be linear or nonlinear depending on the detector response. Resolution describes separation between adjacent peaks, while tailing factor and plate count describe peak shape and column efficiency. Performance checks verify these values before and during a run to confirm that the instrument is performing within limits.
High-performance liquid chromatography testing separates components of a liquid sample by forcing a mobile phase through a packed column. The stationary phase inside the column interacts with analytes to different degrees, so each compound exits at a characteristic retention time. A pump delivers solvent at controlled flow and pressure, while an injector introduces a precise sample volume. Detectors such as ultraviolet-visible, fluorescence, refractive index, or mass spectrometric instruments record the separated bands. The resulting chromatogram provides qualitative and quantitative information about the mixture.
Routine quality control includes blanks, duplicates, spiked samples, and certified reference materials. Calibration curves are prepared with standards at several concentrations, and the detector response is checked for linearity. Carryover, column aging, mobile phase evaporation, and temperature drift can shift retention times or peak areas. Maintenance such as replacing seals, filters, and columns helps prevent failures. Records of injections, integration, and deviations support traceability. Audits may request raw data and instrument logs for each batch.
Developing an HPLC test begins with defining the analytes, matrix, and required reporting limits. Chemists select a separation mode, column chemistry, mobile phase composition, flow rate, and detection wavelength or mass transition. Experiments then adjust these variables to achieve adequate retention, resolution, and peak shape. System suitability tests confirm that the instrument and method perform consistently before sample analysis. Without suitable resolution, quantitative results may be unreliable. Preliminary runs often use scouting gradients to locate retention windows.
| Property | Value | Notes |
|---|---|---|
| Separation mode | Reversed-phase | Common for polar and moderately polar analytes |
| Typical column length | 100-250 mm | Shorter columns can reduce run time |
| Particle size | 3-5 micrometers | Smaller particles improve efficiency but raise pressure |
| Flow rate | 0.5-2.0 mL/min | Depends on column dimensions and pressure limits |
| Detection | UV-Vis absorbance | Widely used for compounds with chromophores |
Routine HPLC testing compares a sample result with a calibration curve prepared from known reference standards. Peak area or peak height is plotted against concentration, and the curve is used to estimate unknown amounts. Retention time supports tentative identification when compared with a standard, though mass spectrometry or another confirmatory method may be needed for definitive identification. Pre-run checks verify repeatability, resolution, and peak symmetry before sample analysis. Limits of detection and quantification describe the smallest amounts that can be reliably observed or measured. Sample preparation, filtration, and degassing help prevent column damage and inconsistent results.
High-performance liquid chromatography is an analytical technique that separates components in a liquid sample. A pump moves a liquid mobile phase through a column packed with a solid stationary phase. Compounds interact differently with both phases and travel at different rates, leaving the column at distinct retention times. A detector records these arrivals as peaks on a chromatogram. The resulting pattern supports identification and quantification of substances in mixtures. Modern instruments use high pressure to force solvent through small particles, which improves speed and resolution compared with older low-pressure liquid chromatography methods.
Separation in HPLC depends on the chemistry of the stationary phase, the composition of the mobile phase, and the physical properties of the column. Reverse-phase separations use a nonpolar stationary phase and a polar mobile phase, and they are common for many organic compounds. Ion-exchange, size-exclusion, and normal-phase modes serve other classes of analytes. Gradient elution changes solvent strength over time, while isocratic elution holds it constant. Flow rate, temperature, particle size, and column length all influence peak shape and resolution. Detection may use ultraviolet absorbance, fluorescence, refractive index, or mass spectrometry, depending on the analyte and the required sensitivity.
The biosynthesis of tacrolimus is hybrid synthesis of both type 1 polyketide synthases (PKS 1) and nonribosomal peptide syntheses (NRPS). The research shows the hybrid synthesis consists of ten modules of type 1 polyketide synthase and one module of nonribosomal peptide synthase. The synthetic enzymes for tacrolimus are found in 19 gene clusters named fkb. The 19 genes are fkbQ, fkbN, fkbM, fkbD, fkbA, fkbP, fkbO, fkbB, fkbC, fkbL, fkbK, fkbJ, fkbI, fkbH, fkbG, allD, allR, allK and allA. There are several possible ways of biosynthesis of tacrolimus. The fundamental units for biosynthesis are following: one molecule of 4,5-dihydroxycyclohex-1-enecarboxylic acid (DHCHC) as a starter unit, four molecules of malonyl-CoA, five molecules of methylmalonyl-CoA, one molecule of allylmalonyl-CoA as elongation units. However, two molecules of malonyl-CoA are able to be replaced by two molecules of methoxymalonyl CoA. Once two malonyl-CoA molecules are replaced, post-synthase tailoring steps are no longer required where two methoxymalonyl CoA molecules are substituted. The biosynthesis of methoxymalonyl CoA to Acyl Carrier protein is proceeded by five enzymes (fkbG, fkbH, fkbI, fkbJ, and fkbK). Allylmalonyl-CoA is also able to be replaced by propionylmalonyl-CoA. The starter unit, DHCHC from the chorismic acid is formed by fkbO enzyme and loaded onto CoA-ligase domain (CoL). Then, it proceeds to NADPH dependent reduction(ER). Three enzymes, fkbA,B,C enforce processes from the loading module to the module 10, the last step of PKS 1.
=== 1977 === January 1: Charter 77 is signed by Czechoslovak intellectuals, including Václav Havel. January 20: Jimmy Carter becomes President of the United States. March 8: A rebellion occurred in the Shaba Province, Zaire. May 30: The Mozambican Civil War begins. June 6: U.S. Secretary of State Cyrus Vance assures skeptics that the Carter administration will hold the Soviet Union accountable for its recent crackdowns on human rights activists. June 27: The French Territory of the Afars and the Issas (modern day Djibouti) becomes independent from France. June 30: The Carter administration cancels the planned Rockwell B-1 Lancer bomber. June 30: SEATO formally dissolves after a loss of confidence in the organisation. July 21–24: Egypt and Libya fought a war at the Egyptian-Libyan border. July 23: The Ogaden War begins when Somalia attacks Ethiopia.
In the version often prepared in the United States today in restaurants and hotels, it consists of strips of beef filet with a mushroom, onion, and sour cream sauce, and is served over rice or noodles. Today, the dish is generally served over wide or twisted egg noodles in the United States.
=== 2000–present === In September 2002, Lilly partnered with Amylin Pharmaceuticals to develop and commercialize Amylin's new drug based on exendin-4, a novel substance isolated from the venom of the Gila monster. Exenatide, the first of the GLP-1 receptor agonists, was approved by the US Food and Drug Administration in April 2005. In 2003, Lilly introduced Cialis (tadalafil), a competitor to Viagra for erectile dysfunction developed in a partnership with Icos. Cialis maintains an active period of 36 hours, causing it sometimes to be dubbed the "weekend pill". It was advertised during the 2004 Super Bowl XXXVIII and 2005 Super Bowl XXXIX halftime shows. In 2004, Lilly introduced duloxetine (Cymbalta), a serotonin-norepinephrine reuptake inhibitor used predominantly in the treatment of major depressive disorders and generalized anxiety disorder. It ranks with Prozac as one of the most financially successful pharmaceuticals in industry history. It is also used in the treatment of fibromyalgia, neuropathy, chronic pain and osteoarthritis. In January 2007, Lilly acquired Icos for $2.1 billion, after raising its offer and facing opposition from Institutional Shareholder Services. Lilly subsequently closed Icos' manufacturing operations, terminated nearly 500 Icos employees, leaving 127 employees working at the biologics facility. In December 2007, CMC Biopharmaceuticals A/S (CMC), a Copenhagen-based provider of contract biomanufacturing services, bought the Bothell, Washington-based biologics facility from Lilly and retained the existing 127 employees.
=== Phase 2 === Abatacept (Orencia) – injection – alopecia areata – T cell activation inhibitor Amlitelimab (KY-1005, SAR-445229) – subcutaneous injection – alopecia areata – OX40 ligand inhibitor BAY-1158061 (HMI-115) – subcutaneous injection – alopecia – prolactin receptor monoclonal antibody (prolactin receptor inhibitor) Bempikibart (ADX-914, BMS-986265) – subcutaneous injection – alopecia areata – CRLF2 protein antagonist, interleukin 7 receptor α subunit inhibitor Bimatoprost (Lumigan) – topical – alopecia – prostaglandin F receptor agonist (prostaglandin F2α analogue) Botulinum toxin A (Xeomin; incobotulinum toxin A) – intradermal – alopecia – acetylcholine release inhibitor and neuromuscular blocking agent CKD-498 – oral – alopecia – undefined mechanism of action Daxdilimab (HZN-7734; MEDI-7734; VIB-7734) – oral – alopecia areata – anti-ILT7 human monoclonal antibody/dendritic cell inhibitor Delgocitinib (Anzupgo, Corectim; JTE-052, LEO-124249, LP-0133) – unknown – alopecia areata – Janus kinase inhibitor Deucravacitinib (Sotyktu; BMS-986165) – oral – alopecia areata – TYK2 kinase inhibitor Finasteride/latanoprost/minoxidil (TH-07; Triple Hair) – topical – alopecia – combination drug/multiple mechanisms of action FOL-005 (osteopontin-derived peptide) – intradermal – alopecia – undefined mechanism of action GT-20029 (AR-PROTAC) – topical – alopecia – androgen receptor degradation enhancer KL-130008 – oral – alopecia areata – Janus kinase inhibitor Latanoprost (DLQ01; DLQ-01) – topical – androgenic alopecia – prostaglandin F receptor agonist (prostaglandin F2α analogue) NXC-736 – oral – alopecia areata – sphingosine 1 phosphate receptor antagonist Rezpegaldesleukin (Rezpeg; LY-3471851, NKTR-358) – unknown – alopecia areata – interleukin-2 conjugate/modulator RK-023 (nobiprostolan) – topical – alopecia, hypotrichosis – undefined mechanism of action (prostaglandin F2α analogue) Rosnilimab (ANB-030) – subcutaneous injection – alopecia areata – programmed cell death 1 receptor agonist Ruxolitinib (Jakafi, Jakavi, Opzelura; INCB-018424) – topical – alopecia areata – Janus kinase 1 inhibitor, Janus kinase 2 inhibitor SIS-302-AA – unspecified – alopecia areata – undefined mechanism of action Suvomipic (PP405; PP-405; JXL069; JXL-069) – topical – alopecia – mitochondrial pyruvate carrier (MPC) inhibitor SYHX-1901 – oral – alopecia areata – Janus kinase inhibitor, Syk kinase inhibitor TDM-105795 (CU-40101) – topical – alopecia – thyroid hormone receptor agonist
Sources: en.wikipedia.org
=== European Union === Use of zinc pyrithione is prohibited within cosmetic products in the European Union since December 2021. The substance was considered safe for use in rinse-off and leave-in products of different tested concentrations, but due to potential environmental toxicity consideration of the use of zinc pyrithione was made against potential alternative substance ingredients. Due to no industry submission to the regulators supporting the continued use of zinc pyrithione and/or an absence of indications that there were no suitable alternatives to the substance: the use of zinc pyrithione became automatically prohibited within cosmetic products as an intended ingredient. This was as a consequence of zinc pyrithione addition to the Cosmetic Product Regulation (EC) No 1223/2009 Annex II list.
Cold Spring Tavern was established as a stagecoach stop in 1865. Originally known as the "Cold Spring Relay Station", it was a horse changeover and meals break station. The tavern is located 20 minutes north of Santa Barbara, California, in Cold Spring Canyon, which is about a mile off Highway 154 along Stagecoach Road (in the San Marcos Pass area).
=== Distribution, phenology, and ecology === Fungarium records provide a historical record of global biodiversity that can be linked to environmental change. Georeferenced metadata allow researchers to connect specimens to historical climate and land-use databases such as WorldClim. Analysis of collection dates in Europe has revealed delays in the autumnal fruiting season and a general widening of the season for saprotrophic fungi. Specimens have also been used to trace invasive species; for example, the introduction and spread of Amanita phalloides in the western United States was reconstructed using DNA from collections spanning a century. Stable carbon and nitrogen isotope analysis of sporocarps in the genus Ramaria has confirmed their nutritional modes and roles in carbon cycling. Although many historical records lack geographic coordinates or contain only vague locality descriptions, retrospective georeferencing can make older specimens more useful for spatial analyses such as species distribution modelling, provided the associated uncertainty is documented.
An unexpected medical problem that happens during treatment with a drug or other therapy. Adverse events do not have to be caused by the drug or therapy, and they may be mild, moderate, or severe. (NCI) An AE is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and that does not necessarily have a causal relationship with this treatment. An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product (see the ICH guidance for Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). (ICH E6) Adverse reaction
=== Flowering === Flowering is triggered by day length, often beginning once days become shorter than 12.8 hours. This trait is highly variable however, with different varieties reacting differently to changing day length. Soybeans form inconspicuous, self-fertile flowers which are borne in the axil of the leaf and are white, pink or purple. Though they do not require pollination, they are attractive to bees, because they produce nectar that is high in sugar content. Depending on the soybean variety, node growth may cease once flowering begins. Strains that continue nodal development after flowering are termed "indeterminates" and are best suited to climates with longer growing seasons. Often soybeans drop their leaves before the seeds are fully mature.
Sources: en.wikipedia.org
adsorption The chemical adhesion of atoms, ions, or molecules of one substance (either a gas, liquid, or dissolved solid) to the surface of another substance, resulting in a film of the first substance being weakly bonded to the interface between the two substances. Adsorption differs from absorption in that it is exclusively a surface phenomenon, while absorption involves entire volumes of materials.
For services to the community in Ross-on-Wye, Herefordshire. Sylvia Joan West. For services to the community in County Down. The Venerable Thomas Roderic West. Minister, Church of Ireland. For services to the community in County Down. David Wheeler. Chair, Lisnaskea Rovers Football Club. For services to Association Football in County Fermanagh. Martin John White. For services to Music in Northern Ireland. Dorothy Margaret Whittington. Volunteer, Oxford University Newcomers. For services to Volunteering and Higher Education. Gwendoline Ann Wickham. President, Guild of the Royal Hospital of St Bartholomew. For services to Charity and to the community in London. Dr Jane Wilcock. Chair, North West Faculty, Royal College of General Practitioners and lately General Practitioner, Silverdale Medical Practice, Swinton, Greater Manchester. For services to General Practice. Martin Peter Wild. For services to the community in Tamworth, Staffordshire. Jonathan Peter Willcocks. Musical Director, The Chichester Singers. For services to Music. Matthew James Willer. Founder, The Papillon Project. For services to Young People. Goodeson Lloyd Williams. For services to the community in the London Borough of Enfield during Covid-19. Howard Mansell Williams. For services to the Royal British Legion and to the community in Spondon, Derbyshire. Joan Barbara Williams. Diary Manager, Minister of State for Industry and Economic Security, Department for Business and Trade. For Public Service. Linda Elaine Williams. Volunteer Support Administrator, Welsh Ambulance Services NHS Trust.
(2022), found that 82% of clinical psychology, counselling psychology, and school psychology graduate students and faculty members in United States and Canada experienced mental health conditions at some points of their lives. The idea of the wounded healer has since expanded to include the study of any professional healers who have been wounded themselves, including counselors, psychotherapists, doctors and nurses.
== Export == Sinokrot holding has expanded their businesses of medjoul dates (Pal Gardens Agriculture Company) to the european markets. Building relationships with big European Dates distributors such as Dadelskopen.
Sources: en.wikipedia.org
It measures the amounts and identities of compounds in liquid samples by separation and detection. Depending on the detector and reference standards, results can be qualitative or quantitative. The technique is used in fields such as pharmaceutical analysis, food safety, and environmental monitoring.
Performance checks confirm that the chromatographic system works within preset limits before results are accepted. They examine factors such as peak resolution, tailing, and repeatability. If criteria fail, the run may need correction or repetition.
Retention time alone is not definitive proof because other compounds can elute at similar times. Confirmation usually uses a second method, a different column, or a detector such as mass spectrometry. Authentic standards strengthen identification.
System suitability is a set of checks performed before and during a run to confirm that the instrument, column, and method work as expected. Common checks include resolution, tailing factor, theoretical plates, and relative standard deviation of replicate injections. Failure triggers troubleshooting or method adjustment.